Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Yang X et al. | 2019 | intact cell/cell culture, FL cells (human amniotic cells) | 50/60 Hz, magnetic field | 0.4 mT |
Cui Y et al. | 2014 | intact cell/cell culture, HEK 293 cells (human embryonic kidney cell line) and cortical neurons (cultured from embryonic ICR mice) | magnetic field, 50/60 Hz | 200 µT |
Karabakhtsian R et al. | 1994 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz | 8 µT |
Golbach LA et al. | 2015 | intact cell/cell culture, HL-60 and PLB-985 cells (human acute myeloid leukaemia cell lines) | magnetic field, low frequency, intermediate frequency, 50/60 Hz, co-exposure | 5 µT–2.5 mT |
Duong CN et al. | 2016 | intact cell/cell culture, HMO6 cells (human microglial cell line) | magnetic field, low frequency, 50/60 Hz, co-exposure | 0.01–1 mT |
Lindstrom E et al. | 1998 | intact cell/cell culture, Jurkat cells (T-lymphocyte hybridoma cell line; clone E6-1 wild type and four derivative clones) | magnetic field, 50/60 Hz | 100–150 µT |
Lyle DB et al. | 1997 | intact cell/cell culture, Jurkat cells (clone E6-1; T-lymphocyte hybridoma cell line) | magnetic field, 50/60 Hz | 150 µT |
Galvanovskis J et al. | 1996 | intact cell/cell culture, Jurkat cells (clone E6-1; T-lymphocyte hybridoma cell line) | magnetic field, 50/60 Hz | 100 µT |
Galvanovskis J et al. | 1999 | intact cell/cell culture, Jurkat cells (clone E6-1; T-lymphocyte hybridoma cell line) | magnetic field, 50/60 Hz | 50–400 µT |
Wey HE et al. | 2000 | intact cell/cell culture, Jurkat cells (clone E6-1; T-lymphocyte hybridoma cell line) | magnetic field, 50/60 Hz | 150 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.